About Xevant
Xevant is a company based in Draper (United States) founded in 2017 by Brandon Newman. Xevant has raised $17.18 million across 3 funding rounds from investors including HCAP Partners, Tech Council Ventures and HCAP Partners. The company has 42 employees as of December 31, 2022. Xevant offers products and services including Xevant Platform, DataLogic, AlertLogic, ScripLogic, and Ivím at Work. Xevant operates in a competitive market with competitors including mPharma, Pharmarack, OmniSYS, Scripta Insights and KareXpert, among others.
- Headquarter Draper, United States
- Employees 42 as on 31 Dec, 2022
- Founders Brandon Newman
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xevant
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.18 M (USD)
in 3 rounds
-
Latest Funding Round
$9.07 M (USD), Series A
Feb 08, 2024
-
Investors
HCAP Partners
& 4 more
-
Employee Count
42
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xevant
Xevant offers a comprehensive portfolio of products and services, including Xevant Platform, DataLogic, AlertLogic, ScripLogic, and Ivím at Work.
AI-driven tool for optimizing pharmacy benefits and costs
Automates pharmacy claims analysis for cost savings
Provides alerts for performance issues in benefits data
Manages script data for rebate and utilization tracking
Supports corporate weight management programs
People of Xevant
Unlock access to complete
Funding Insights of Xevant
Xevant has successfully raised a total of $17.18M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $9.07 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Xevant
Xevant has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HCAP Partners, Tech Council Ventures and HCAP Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth capital is provided by HCAP Partners to established businesses.
|
Locked | Locked | Locked | |
|
VC investments are directed at seed-to-growth tech startups in Mid-Atlantic.
|
Locked | Locked | Locked | |
|
Venture capital and private equity investments are provided by Martinson Ventures.
|
Locked | Locked | Locked |
Investor details for Xevant
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xevant
Investment portfolio details for Xevant
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xevant
Detailed financials for Xevant
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xevant Comparisons
Peer comparison for Xevant
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xevant
Xevant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as mPharma, Pharmarack, OmniSYS, Scripta Insights and KareXpert, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of pharmacy management services and software for stock management for patients and pharmacies
|
|
| Locked | Locked | Locked |
SaaS-based pharmacy management solutions are offered to retailers and distributors.
|
|
| Locked | Locked | Locked |
Offers medical billing services for pharmacies and manages business policies and relationships.
|
|
| Locked | Locked | Locked |
AI-driven pharmacy benefit management software is provided for pharmacies.
|
|
| Locked | Locked | Locked |
Cloud-based software suite for healthcare providers is offered.
|
Detailed competitors of Xevant
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xevant
Complete news archive for Xevant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xevant
Xevant was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Xevant is headquartered in Draper, United States. It is registered at Draper, Utah, United States.
Brandon Newman is the current CEO of Xevant. They have also founded this company.
Xevant is a funded company, having raised a total of $17.18M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Xevant is 42.
Xevant was founded in 2017 and is headquartered in Draper, United States, within the healthcare technology sector. SaaS solutions for pharmacy benefit management are offered, including ScripLogic for analyzing benefits in pharmacies. ClinicalLogic supports benefit plans with real-time data analysis, while BidLogic manages claims processing. FinanceLogic delivers financial insights to pharmacies. An automated system enables customized medical benefits for pharmacy operations.
Xevant's top competitors include mPharma, Scripta Insights and KareXpert.
Xevant offers Xevant Platform, DataLogic, AlertLogic, ScripLogic, and Ivím at Work.
Xevant has 5 investors. Key investors include HCAP Partners, Tech Council Ventures, HCAP Partners, Martinson Ventures, and Boston Millennia Partners.